keyword
MENU ▼
Read by QxMD icon Read
search

Aripiprazole delirium

keyword
https://www.readbyqxmd.com/read/26589880/aripiprazole-a-new-option-in-delirium
#1
Eric Prommer
Delirium is a palliative care emergency where patients experience changes in perception, awareness, and behavior. Common features include changes in the sleep-wake cycle, emotional lability, delusional thinking, and language and thought disorders. Delirium results from neurotransmitter imbalances involving several neurotransmitters such as dopamine, glutamate, norepinephrine, acetylcholine, gamma-aminobutyric acid, and serotonin. Untreated delirium causes significant morbidity and mortality. Nonpharmacologic and pharmacologic approaches treat delirium...
November 20, 2015: American Journal of Hospice & Palliative Care
https://www.readbyqxmd.com/read/26502575/-alcohol-withdrawal-syndrome-showing-various-progress-a-case-report
#2
Chihiro Nakata, Keinosuke Nara, Fumihiko Kinoshita, Ken Kikuchi, Masahiro Asai
We experienced a case showing various psychotic symptoms following cessation of alcohol consumption. The symptoms included depressive state, delusion, confusion, psychomotor excitement and delirium, all of which disappeared in about two months. At first, we regarded all the symptoms as alcoholic hallucinosis, by a clinical standpoint, in spite of no auditory hallucination in this case. However, taking the overall clinical course into consideration, withdrawal syndrome could have been affected by some factors...
June 2015: Nihon Arukōru Yakubutsu Igakkai Zasshi, Japanese Journal of Alcohol Studies & Drug Dependence
https://www.readbyqxmd.com/read/26341326/antipsychotic-medications-for-the-treatment-of-delirium-a-systematic-review-and-meta-analysis-of-randomised-controlled-trials
#3
Taro Kishi, Tomoya Hirota, Shinji Matsunaga, Nakao Iwata
OBJECTIVES: We performed an updated meta-analysis of antipsychotic treatment in patients with delirium, based on a previous meta-analysis published in 2007. METHODS: Included in this study were randomised, placebo-controlled or usual care (UC) controlled trials of antipsychotics in adult patients with delirium. Our primary outcome measure was response rate at the study end point. The secondary outcome measures included improvement of severity of delirium, Clinical Global Impression-Severity Scale (CGI-S), time to response (TTR), discontinuation rate and individual adverse effects...
July 2016: Journal of Neurology, Neurosurgery, and Psychiatry
https://www.readbyqxmd.com/read/25838319/atypical-neuroleptic-malignant-syndrome-in-patients-treated-with-aripiprazole-and-clozapine-a-case-series-study-and-short-review
#4
REVIEW
Ping-Tao Tseng, Yi-Chung Chang, Chih-Hua Chang, Hung-Yu Wang, Yu-Shian Cheng, Ching-Kuan Wu, Yen-Wen Chen, Weilun Chung
OBJECTIVES: Neuroleptic malignant syndrome (NMS) requires emergency treatment and can be fatal. Combined aripiprazole and clozapine therapy is rarely used in clinical settings, and NMS related this combination still lacks evaluation. Herein, we present two cases of atypical NMS treated with aripiprazole and clozapine. METHODS: Case 1 was a schizophrenic male with a history of NMS under treatment with aripiprazole 20 mg. He was hospitalized and maintained with aripiprazole 5 mg and clozapine 225 mg...
2015: International Journal of Psychiatry in Medicine
https://www.readbyqxmd.com/read/25663153/management-of-delirium-in-palliative-care-a-review
#5
REVIEW
Luigi Grassi, Augusto Caraceni, Alex J Mitchell, Maria Giulia Nanni, Maria Alejandra Berardi, Rosangela Caruso, Michelle Riba
Delirium is a complex but common disorder in palliative care with a prevalence between 13 and 88 % but a particular frequency at the end of life (terminal delirium). By reviewing the most relevant studies (MEDLINE, EMBASE, PsycLit, PsycInfo, Cochrane Library), a correct assessment to make the diagnosis (e.g., DSM-5, delirium assessment tools), the identification of the possible etiological factors, and the application of multicomponent and integrated interventions were reported as the correct steps to effectively manage delirium in palliative care...
March 2015: Current Psychiatry Reports
https://www.readbyqxmd.com/read/25514894/use-of-aripiprazole-for-delirium-in-the-elderly-a-short-review
#6
REVIEW
Eiji Kirino
The effects and tolerability of antipsychotics in delirium treatment remain controversial. Compared to other antipsychotics, aripiprazole differs in pharmacological activity because it exerts its effect as a dopamine D2 partial agonist. The guidelines of the American Psychiatric Association rank aripiprazole highly among antipsychotics with regard to safety, and this drug is likely to be useful for delirium treatment. Here, we reviewed the efficacy and safety of aripiprazole for delirium. The results of our literature review on the efficacy and safety of delirium treatments suggest that aripiprazole is an effective treatment option for delirium in the elderly...
March 2015: Psychogeriatrics: the Official Journal of the Japanese Psychogeriatric Society
https://www.readbyqxmd.com/read/25424243/post-injection-delirium-sedation-syndrome-in-patients-treated-with-olanzapine-pamoate-mechanism-incidence-and-management
#7
REVIEW
Daniel Luedecke, Daniel Schöttle, Anne Karow, Martin Lambert, Dieter Naber
Second-generation antipsychotics (SGAs) are a mainstay in the treatment of patients with schizophrenia. However, continuity in intake of the prescribed medication has been one of the greatest challenges in these patients. One option to improve medication adherence is to prescribe depot or long-acting injectable formulations (LAIs) of antipsychotics. Following risperidone, several other SGAs have been introduced as LAIs. Olanzapine pamoate, paliperidone palmitate, and aripiprazole are the new-generation LAIs, which are available for 2- to 4-week intervals of application in many countries...
January 2015: CNS Drugs
https://www.readbyqxmd.com/read/25191793/haloperidol-risperidone-olanzapine-and-aripiprazole-in-the-management-of-delirium-a-comparison-of-efficacy-safety-and-side-effects
#8
COMPARATIVE STUDY
Soenke Boettger, Josef Jenewein, William Breitbart
OBJECTIVE: The aim of this study was to compare the efficacy and side-effect profile of the typical antipsychotic haloperidol with that of the atypical antipsychotics risperidone, olanzapine, and aripiprazole in the management of delirium. METHOD: The Memorial Delirium Assessment Scale (MDAS), the Karnofsky Performance Status (KPS) scale, and a side-effect rating were recorded at baseline (T1), after 2-3 days (T2), and after 4-7 days (T3). Some 21 cases were case-matched by age, preexisting dementia, and baseline MDAS scores, and subsequently analyzed...
August 2015: Palliative & Supportive Care
https://www.readbyqxmd.com/read/23780619/long-acting-injectable-formulations-of-new-generation-antipsychotics-a-review-from-a-clinical-perspective
#9
REVIEW
Anna-Sophia Rauch, W Wolfgang Fleischhacker
Antipsychotics are the mainstay of the long-term treatment of patients with schizophrenia. In this context, the evidence also supports the effectiveness of long-acting injections (LAIs) or depots of antipsychotics regarding their relapse-preventing properties. When a LAI formulation of risperidone was launched as the first second-generation depot, there was a renaissance of interest in these formulations. In the meantime, olanzapine, paliperidone, and aripiprazole have been approved by regulatory authorities as LAIs in various countries...
August 2013: CNS Drugs
https://www.readbyqxmd.com/read/23503785/-pharmacological-treatment-of-delirium-in-palliative-care-patients-a-systematic-literature-review
#10
REVIEW
K M Perrar, H Golla, R Voltz
This systematic literature review aims to collect and analyse relevant clinical trials for the drug treatment of delirium in palliative care. The search was conducted including July 2012 in Medline (from 1966) and Embase (from 1974). The search retrieved 448 studies, of which 3 studies could be included in the analysis. Treatment with the antipsychotic drug haloperidol can be recommended, which is also true to a somewhat lower extent for the antipsychotics olanzapine and aripiprazole. Treatment with lorazepam only should be avoided...
April 2013: Der Schmerz
https://www.readbyqxmd.com/read/23503549/long-acting-injectable-antipsychotics-and-the-development-of-postinjection-delirium-sedation-syndrome-pdss
#11
REVIEW
Vladan Novakovic, Tymaz Adel, Eric Peselow, Jean-Pierre Lindenmayer
OBJECTIVES: Five long-acting injectable (LAI) antipsychotics are currently available in the United States for the treatment of schizophrenia: fluphenazine decanoate, haloperidol decanoate, risperidone microspheres, paliperidone palmitate, and olanzapine pamoate. Additionally, aripiprazole LAI is currently under FDA review. However, research into the safety and tolerability of these LAIs, with particular regard to the development of postinjection delirium/sedation syndrome (PDSS), is limited and has been focused mainly on olanzapine pamoate...
March 2013: Clinical Neuropharmacology
https://www.readbyqxmd.com/read/23362038/torsades-de-pointes-after-administration-of-low-dose-aripiprazole
#12
Sarah Nelson, Jonathan G Leung
OBJECTIVE: To describe a case of torsades de pointes (TdP) in a patient treated with aripiprazole. CASE SUMMARY: A 42-year-old white male with schizophrenia, diabetes, hypertension, and a history of stroke was admitted to the intensive care unit following 2 days of fever, diarrhea, and altered mental status. Following the resolution of his acute illness, previous therapy with quetiapine 400 mg orally at bedtime was resumed for schizophrenia and presumed delirium...
February 2013: Annals of Pharmacotherapy
https://www.readbyqxmd.com/read/23341158/pharmacotherapy-considerations-in-patients-with-hiv-and-psychiatric-disorders-focus-on-antidepressants-and-antipsychotics
#13
REVIEW
Lucas Hill, Kelly C Lee
OBJECTIVE: To review the evidence for the efficacy and safety of pharmacologic agents for the treatment of depressive and psychotic disorders in patients with HIV infection and to provide clinical considerations for the treatment of depression and psychosis in these patients. DATA SOURCES: PubMed was searched for articles published between 1966 and August 1, 2012, using the search terms antiretrovirals, HIV, AIDS, depression, psychosis, schizophrenia, antidepressant, antipsychotic, and individual drug names (fluoxetine, sertraline, paroxetine, citalopram, escitalopram, venlafaxine, duloxetine, mirtazapine, bupropion, haloperidol, perphenazine, fluphenazine, aripiprazole, asenapine, clozapine, iloperidone, lurasidone, olanzapine, paliperidone, quetiapine, risperidone, ziprasidone)...
January 2013: Annals of Pharmacotherapy
https://www.readbyqxmd.com/read/22980477/-dysphagia-or-dysphagias-during-neuroleptic-medication
#14
N Chaumartin, M Monville, B Lachaux
INTRODUCTION: Dysphagia is a common symptom in the general population, and even more among psychiatric patients, but rarely seen as a sign of seriousness. It is a cause of death by suffocation, and more or less serious complications, and therefore should be diagnosed and treated. Among psychiatric patients, organic and iatrogenic aetiologies, as well as risk factors are identified, which worsen this symptom when associated. It is now accepted that neuroleptics can aggravate or cause dysphagia...
September 2012: L'Encéphale
https://www.readbyqxmd.com/read/22104410/an-open-trial-of-aripiprazole-for-the-treatment-of-delirium-in-hospitalized-cancer-patients
#15
Soenke Boettger, William Breitbart
OBJECTIVE: The purpose of this study was to examine the efficacy and safety of aripiprazole in the treatment of delirium in hospitalized cancer patients, and to examine differential responses based on delirium subtypes. METHOD: We conducted an analysis of 21 hospitalized cancer patients at Memorial Sloan-Kettering Cancer Center (MSKCC) who had been evaluated and treated for delirium with aripiprazole, using an MSKCC Institutional Review Board (IRB) approved Clinical Delirium Database...
December 2011: Palliative & Supportive Care
https://www.readbyqxmd.com/read/21563866/aripiprazole-and-haloperidol-in-the-treatment-of-delirium
#16
COMPARATIVE STUDY
Soenke Boettger, Miriam Friedlander, William Breitbart, Steven Passik
OBJECTIVE: To compare the efficacy and tolerability of aripiprazole and haloperidol in the amelioration of distressing symptoms of delirium and its motoric subtypes. METHODS: At Memorial Sloan-Kettering Cancer Center, we prospectively collected sociodemographic and medical data and systematically rated all patients diagnosed with delirium with the Memorial Delirium Assessment Scale (MDAS), Karnofsky Performance Scale (KPS) and the abbreviated Udvalg Kliniske Undersogelser Side Effect Rating Scale (UKU) at the initial diagnosis of delirium (T1), after 48-72 h (T2) and 7 days later (T3)...
June 2011: Australian and New Zealand Journal of Psychiatry
https://www.readbyqxmd.com/read/19473954/-atypical-antipsychotic-efficacy-and-safety-in-managing-delirium-a-systematic-review-and-critical-analysis
#17
REVIEW
Camille Pelland, Jean-François Trudel
Delirium is a common syndrome in hospitalised patients, particularly in the elderly. While haloperidol has long been the preferred treatment, atypical antipsychotics are now often used, even though their efficacy and safety remain unclear. The review was intended to identify published studies on use of olanzapine, risperidone, quetiapine, ziprasidone, and aripiprazole in managing delirium; to assess their methodological quality; and to formulate clinical recommendations. From Medline and Embase databases (1996-2008), we included all retrospective and prospective group studies that made use of standardised symptom rating scales...
June 2009: Psychologie & Neuropsychiatrie du Vieillissement
https://www.readbyqxmd.com/read/18601302/delirium-and-its-treatment
#18
REVIEW
Azizah Attard, Gopinath Ranjith, David Taylor
Delirium occurs at rates ranging from 10% to 30% of all hospital admissions. It is a negative prognostic indicator, often leading to longer hospital stays and higher mortality. The aetiology of delirium is multifactorial and many causes have been suggested. The stress-diathesis model, which posits an interaction between the underlying vulnerability and the nature of the precipitating factor, is useful in understanding delirium. Preventing delirium is the most effective strategy for reducing its frequency and complications...
2008: CNS Drugs
https://www.readbyqxmd.com/read/18597728/-clinical-potentialities-and-perspectives-for-the-use-of-aripiprazole-in-other-disorders-than-its-classical-indications-a-critical-analysis-of-the-recent-literature
#19
REVIEW
M-A Crocq, V Camus, B Millet, J Gliskman, J-M Azorin, M-O Krebs, F Limosin, J Costentin, J Daléry
Aripiprazole is indicated for the treatment of schizophrenia in Europe and the United States, and for bipolar disorders in the latter. Nevertheless, a review of recent literature has shown that aripiprazole has been studied in many other disorders, notably resistant depression, anxiety, obsessive-compulsive disorder, borderline personality, Tourette syndrome, addiction, psychotic symptoms in children and adolescents, and neurological and psychiatric disorders in the elderly (late onset delusional disorders, Alzheimer, Parkinson, and delirium)...
April 2008: L'Encéphale
https://www.readbyqxmd.com/read/17613966/efficacy-and-safety-of-aripiprazole-in-alcohol-dependence
#20
Giovanni Martinotti, Marco Di Nicola, Luigi Janiri
Dopaminergic agonists and antagonists have both been examined for the treatment of substance abuse with contrasting results. To the best of our knowledge dopamine receptor partial agonists have not been investigated in alcohol use disorders. Thirteen detoxified alcohol-dependent subjects were treated with flexible doses of aripiprazole for 16 weeks. Six patients maintained an alcohol free condition for all the study period. All the subjects experienced a reduction of craving in both OCDS (p < .05) and VAS (p < ...
2007: American Journal of Drug and Alcohol Abuse
keyword
keyword
88913
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"